# Effects of Tolterodine, a Non-Specific Muscarinic Antagonist, on Gastrointestinal Transit in Healthy Subjects

> **NCT00332137** · PHASE2 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 36 (—)

## Conditions studied

- Health

## Interventions

- **DRUG:** Tolterodine

## Key facts

- **NCT ID:** NCT00332137
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** 2007-08
- **Final completion:** 2007-08
- **Target enrollment:** 36 (—)
- **Last updated:** 2011-03-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00332137

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00332137, "Effects of Tolterodine, a Non-Specific Muscarinic Antagonist, on Gastrointestinal Transit in Healthy Subjects". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT00332137. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*